Over 160 L COVID-19 vaccine doses procured so far, but beneficiaries below target due to hesitancy, govt tells LS
Giving out the details of the number of vaccines already procured by the government, Minister of State for Health Ashwini Choubey said the total cost of procurement of above mentioned doses of vaccines is Rs 350.25 crore
Coronavirus News Updates: COVID-19 expert panel recommends emergency use authorisation for Bharat Biotech's COVAXIN
Coronavirus News LIVE Updates: Covaxin has been indigenously developed by Bharat Biotech in collaboration with the ICMR
SEC recommends Bharat Biotech's COVAXIN for emergency use as India tests its vaccine delivery system
The recommendation for Bharat Biotech's vaccine came a day after the COVID-19 expert panel cleared the Serum Institute of India's emergency use authorisation application for the Oxford-AstraZeneca vaccine 'Covishield'
The Subject Expert Committee (SEC) on COVID-19 of the CDSCO noted that the vaccine is an inactivated whole virion, coronavirus vaccine, having the potential to target mutated coronavirus strains, a source told PTI
COVID-19 dry runs: From vaccination rooms to Co-WIN app, here's how mock immunisation drive is held across India
The primary objective of the dry run is to assess the operational feasibility of using the Co-WIN application in a field environment. The app was specially designed to keep a track of Covid-19 vaccination programme and allow Indian citizens to apply for a Covid-19 vaccine shot
COVID-19 panel recommends SII's Covishield for emergency use; new cases remain under 30,000 for 19th day
The daily new coronavirus infections in India remained below 30,000 for the 19th consecutive day on Friday, taking the total caseload to 1,02,86,709
Indian regulator seeks more time as UK authorises Oxford COVID-19 jab; six things about cheap, easy to store vaccine
In India, a decision on emergency usage of the vaccine, which is being manufactured by Pune-based Serum Institute of India, is likely to come next year with the Subject Expert Committee (SEC) on COVID-19 seeking more time today
CDSCO asks Bharat Biotech to submit complete immunogenicity data of Phase 2 trial of COVID-19 vaccine
The vaccine candidate, 'Covaxin', is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research
COVID-19 vaccine: Serum Institute of India to begin Phase 2 trial of Oxford-Astrazeneca candidate today
The DCGI on 3 August had given nod to the Pune Serum Institute of India for conducting phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate
Serum Institute asked to revise protocols for Phase 2, 3 trials of Oxford COVID-19 vaccine candidate
The CDSCO expert panel also recommended that Pune-based firm's proposed clinical trial sites be distributed across India
Though the Minister of State for Health and Family Welfare has a National Vaccine Policy document, it does not address all the problems associated with UIP.
Enhancing delivery of quality health care: Biomedical engineers act as a bridge between modern medicine, engineering
From the concept to market reach and clinical trials, biomedical engineers are part of the health care ecosystem contributing to meeting the SDGs, especially universal health coverage.
Faulty hip implants: Delhi HC asks Johnson & Johnson for interim payment of Rs 25 lakh to 4 patients
The court's direction came after Johnson & Johnson said it was willing to pay Rs 25 lakh as compensation to the patients who were affected by the implants.
Johnson & Johnson’s baby shampoo samples fail Rajasthan drug watchdog's quality tests; company rejects findings
The Rajasthan Drugs Control Organisation’s notice said that the samples of Johnson & Johnson’s baby shampoofailed the quality test
On the directions of the CDSCO, drug inspectors collected samples of Johnson & Johnson's baby powder from both the plants on Wednesday.
Samples of Johnson & Johnson baby powder to be tested as drug inspectors examine mfg facilities: Report
Johnson & Johnson in India did not have any immediate comment on the reports of sample seizures by Indian authorities.
Johnson & Johnson said in a statement that the Reuters article, which was published on Friday, “is one-sided, false and inflammatory.”
Government of India seeks to define stem cells as drug, regulate use in therapy; scientists term move 'long overdue'
The health ministry , in a proposal to amend existing rules, pushed to bring stem cells and cell-based products under legal regulations
Delhi HC sends notice to Centre on sale of skin creams containing steroids, calls misuse of drugs 'serious issue'
The Delhi High Court on Wednesday issued a notice to the Central government on a PIL seeking direction to ensure that no topical medications which contain a "cocktail of harmful steroids" is sold without a valid prescription of a doctor.